We are live on ! Find out more
SI

Sava Infond Portfolio holdings

AUM $1.41B
1-Year Est. Return 69.95%
This Fund
S&P 500
This Quarter Est. Return
+21.32%
1 Year Est. Return
+69.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$640M
AUM Growth
+$116M
Cap. Flow
+$20.3M
Cap. Flow %
3.16%
Top 10 Hldgs %
47.61%
Holding
226
New
11
Increased
71
Reduced
48
Closed
10

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.36M
2
AAPL icon
Apple
AAPL
+$1.77M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.6M
4
MELI icon
Mercado Libre
MELI
+$782K
5
TSLA icon
Tesla
TSLA
+$753K

Sector Composition

Rank Sector Weight
1 Technology 51.15%
2 Communication Services 9.75%
3 Healthcare 8.99%
4 Consumer Discretionary 8.4%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
101
Amgen
AMGN
$203B
$790K 0.12%
2,830
FMX icon
102
Fomento Económico Mexicano
FMX
$43.3B
$787K 0.12%
7,640
TW icon
103
Tradeweb Markets
TW
$21.3B
$783K 0.12%
5,350
RPRX icon
104
Royalty Pharma
RPRX
$26.1B
$757K 0.12%
21,000
GOOG icon
105
Alphabet (Google) Class C
GOOG
$3.9T
$755K 0.12%
4,255
FSLR icon
106
First Solar
FSLR
$21.8B
$745K 0.12%
4,500
+2,600
+137% +$384K
INFY icon
107
Infosys
INFY
$45B
$741K 0.12%
40,000
KNSL icon
108
Kinsale Capital Group
KNSL
$7.95B
$740K 0.12%
1,530
-570
-27% -$266K
IHI icon
109
iShares US Medical Devices ETF
IHI
$3.02B
$735K 0.11%
11,730
-3,470
-23% -$209K
ALNY icon
110
Alnylam Pharmaceuticals
ALNY
$36.3B
$711K 0.11%
2,180
+100
+5% +$27.7K
LEN icon
111
Lennar Class A
LEN
$20.4B
$702K 0.11%
6,350
+2,000
+46% +$217K
VRTX icon
112
Vertex Pharmaceuticals
VRTX
$121B
$699K 0.11%
1,570
ABEV icon
113
Ambev
ABEV
$47.3B
$699K 0.11%
290,000
NTRA icon
114
Natera
NTRA
$37.5B
$676K 0.11%
4,000
CVS icon
115
CVS Health
CVS
$137B
$652K 0.1%
9,450
PDD icon
116
Pinduoduo
PDD
$118B
$638K 0.1%
6,100
-1,200
-16% -$126K
FXI icon
117
iShares China Large-Cap ETF
FXI
$4.31B
$632K 0.1%
17,200
+3,400
+25% +$119K
GREK
118
Global X MSCI Greece ETF
GREK
$288M
$631K 0.1%
10,880
+1,180
+12% +$61.2K
XLE icon
119
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$585K 0.09%
13,800
-1,400
-9% -$58.3K
MXI icon
120
iShares Global Materials ETF
MXI
$338M
$581K 0.09%
6,800
-2,000
-23% -$166K
EQIX icon
121
Equinix
EQIX
$107B
$539K 0.08%
678
DXCM icon
122
DexCom
DXCM
$27.6B
$532K 0.08%
6,100
MSCI icon
123
MSCI
MSCI
$40B
$519K 0.08%
900
-200
-18% -$111K
BDX icon
124
Becton Dickinson
BDX
$43.1B
$505K 0.08%
2,930
JAZZ icon
125
Jazz Pharmaceuticals
JAZZ
$15.9B
$446K 0.07%
4,200
+780
+23% +$84.7K

Similar funds

Sava Infond's Q2 2025 Portfolio in Review

As of Q2 2025, Sava Infond held 226 positions worth $640M, up 22% from $524M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sava Infond deployed $20.3M of net new capital in Q2 2025, opening 11 new positions and adding to 71 existing holdings. Its largest new stake was Nu Holdings: 60,000 shares worth $823K.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 46% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $4.36M trimmed.

  • Sava Infond's largest Q2 2025 buy was Nu Holdings: 60,000 shares worth $823K.
  • Sava Infond added most to Arista Networks in Q2 2025, an estimated $4.02M increase.
  • Sava Infond's biggest Q2 2025 reduction was Microsoft, cutting an estimated $4.36M.
  • Sava Infond fully exited Paychex in Q2 2025, selling an estimated $293K.
  • Sava Infond's ten largest holdings make up 48% of its $640M portfolio in Q2 2025.
  • Sava Infond opened 11 new positions and closed 10 in Q2 2025.
  • Sava Infond's portfolio value rose 22% quarter-over-quarter to $640M.

Based on Sava Infond's 13F filing for Q2 2025, filed 22 Jul 2025.